Pregabalin Tapering from 150 mg Daily
Taper pregabalin 150 mg daily gradually over a minimum of 1 week, as mandated by the FDA label. 1
Recommended Tapering Schedule
The FDA prescribing information explicitly states that when discontinuing pregabalin, you must taper gradually over a minimum of 1 week. 1 While the label does not provide a specific dose reduction schedule, this minimum duration is a regulatory requirement based on safety data.
Practical Tapering Approach
For a patient on 150 mg daily, a reasonable taper would be:
- Week 1: Reduce to 75 mg daily (50% reduction)
- After Week 1: Discontinue completely
Alternatively, for patients with concerns about withdrawal or who have been on therapy longer:
- Days 1-3: 100 mg daily
- Days 4-7: 75 mg daily
- Days 8-10: 50 mg daily
- Day 11: Discontinue
Evidence Supporting Gradual Discontinuation
Research demonstrates that pregabalin carries a low risk of discontinuation symptoms when tapered appropriately. 2 A controlled trial evaluating discontinuation after 12 and 24 weeks of treatment found low levels of withdrawal symptoms across all pregabalin dose ranges (150-600 mg/day), with mean increases on the Physician Withdrawal Checklist of only 1.7-2.8 points. 3 Rebound anxiety rates were also minimal (0-6%) when proper tapering was employed. 3
Clinical Considerations
Duration of therapy matters: The 1-week minimum taper is based on clinical trial data, but patients on longer-term therapy (months to years) may benefit from a more gradual taper over 2-3 weeks to minimize any potential withdrawal effects. 2, 3
Dose-dependent effects: Since pregabalin exhibits dose-dependent adverse reactions and efficacy, the relatively low dose of 150 mg daily suggests withdrawal risk is lower compared to higher doses (300-600 mg/day). 1
Monitor for discontinuation symptoms: Watch for dizziness, insomnia, nausea, headache, or anxiety during the taper period, though these are uncommon at this dose level. 2, 3
Common Pitfall to Avoid
Do not abruptly discontinue pregabalin. The FDA warning specifically mandates gradual tapering over at least 1 week to prevent potential withdrawal symptoms. 1 Even though research suggests pregabalin has lower discontinuation symptom rates compared to benzodiazepines, the regulatory requirement for tapering must be followed. 3